Dr Robbert Hoogeboom is a Lecturer in Lymphoma within the Comprehensive Cancer Centre. He obtained a PhD at the Academic Medical Centre in Amsterdam, The Netherlands and subsequently became a postdoc at the National Institute for Medical Research/The Francis Crick Institute. In 2018, he joined King's College London as a lecturer. He leads a research group that focuses on the role of antigen exposure and B cell receptor signalling in the pathogenesis and treatment of B cell leukaemia and lymphoma. His team uses high content imaging of primary patient cells and novel in vivo mouse models to study the context in which malignant B cells see antigen and how antigen stimulation and BCR signalling influence the behaviour of the tumour cells and disease progression.